<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001957225</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0000012208</issuerCik>
      <issuerName>BIO-RAD LABORATORIES, INC.</issuerName>
      <secFileNumber>001-07928</secFileNumber>
      <issuerAddress>
        <com:street1>1000 ALFRED NOBEL DRIVE</com:street1>
        <com:city>HERCULES</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94547</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>5107247000</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Alles Institute for Medical Research Corp</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common- Class A</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Wells Fargo Clearing Services</name>
        <address>
          <com:street1>1 N. Jefferson</com:street1>
          <com:city>St. Louis</com:city>
          <com:stateOrCountry>MO</com:stateOrCountry>
          <com:zipCode>63103</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>410</noOfUnitsSold>
      <aggregateMarketValue>101539.65</aggregateMarketValue>
      <noOfUnitsOutstanding>22940805</noOfUnitsOutstanding>
      <approxSaleDate>03/11/2025</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common - Class A</securitiesClassTitle>
      <acquiredDate>09/12/2016</acquiredDate>
      <natureOfAcquisitionTransaction>Donation</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Alice Schwartz</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>Y</isGiftTransaction>
      <donarAcquiredDate>09/12/2016</donarAcquiredDate>
      <amountOfSecuritiesAcquired>410</amountOfSecuritiesAcquired>
      <natureOfPayment>Stock In Kind</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>Shares were donated to Alles Institute for Medical Research by Alice Schwartz 9/12/2016 &amp; 12/10/2018. Alice Schwartz is associated with Alles Institute for Medical Research and is also a director and 10 percent shareholder of the issuer.</remarks>
    <noticeSignature>
      <noticeDate>03/11/2025</noticeDate>
      <signature>Julia Schwartz</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3102}]
144
0001957225
XXXXXXXX
LIVE
0000012208
BIO-RAD LABORATORIES, INC.
001-07928
1000 ALFRED NOBEL DRIVE
HERCULES
CA
94547
5107247000
Alles Institute for Medical Research Corp
Director
10% Stockholder
Common- Class A
Wells Fargo Clearing Services
1 N. Jefferson
St. Louis
MO
63103
410
101539.65
22940805
03/11/2025
NYSE
Common - Class A
09/12/2016
Donation
Alice Schwartz
Y
09/12/2016
410
Stock In Kind
Y
Shares were donated to Alles Institute for Medical Research by Alice Schwartz 9/12/2016 & 12/10/2018. Alice Schwartz is associated with Alles Institute for Medical Research and is also a director and 10 percent shareholder of the issuer.
03/11/2025
Julia Schwartz